Literature DB >> 2170159

The time course of the immune response to experimental coronavirus infection of man.

K A Callow1, H F Parry, M Sergeant, D A Tyrrell.   

Abstract

After preliminary trials, the detailed changes in the concentration of specific circulating and local antibodies were followed in 15 volunteers inoculated with coronavirus 229E. Ten of them, who had significantly lower concentrations of pre-existing antibody than the rest, became infected and eight of these developed colds. A limited investigation of circulating lymphocyte populations showed some lymphocytopenia in infected volunteers. In this group, antibody concentrations started to increase 1 week after inoculation and reached a maximum about 1 week later. Thereafter antibody titres slowly declined. Although concentrations were still slightly raised 1 year later, this did not always prevent reinfection when volunteers were then challenged with the homologous virus. However, the period of virus shedding was shorter than before and none developed a cold. All of the uninfected group were infected on re-challenge although they also appeared to show some resistance to disease and in the extent of infection. These results are discussed with reference to natural infections with coronavirus and with other infections, such as rhinovirus infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170159      PMCID: PMC2271881          DOI: 10.1017/s0950268800048019

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  29 in total

1.  The epidemiology of the common cold. I.

Authors:  O M LIDWELL; R E WILLIAMS
Journal:  J Hyg (Lond)       Date:  1961-09

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man.

Authors:  W T Butler; T A Waldmann; R D Rossen; R G Douglas; R B Couch
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

4.  The role of nasal secretion and serum antibody in the rhinovirus common cold.

Authors:  T R Cate; R D Rossen; R G Douglas; W T Butler; R B Couch
Journal:  Am J Epidemiol       Date:  1966-09       Impact factor: 4.897

5.  Protein composition of nasal secretion during respiratory virus infection.

Authors:  R D Rossen; W T Butler; T R Cate; C F Szwed; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

6.  The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus.

Authors:  R D Rossen; W T Butler; R H Waldman; R H Alford; R B Hornick; Y Togo; J A Kasel
Journal:  JAMA       Date:  1970-02-16       Impact factor: 56.272

7.  Community-wide outbreak of infection with a 229E-like coronavirus in Tecumseh, Michigan.

Authors:  J J Cavallaro; A S Monto
Journal:  J Infect Dis       Date:  1970-10       Impact factor: 5.226

8.  The time course of the humoral immune response to rhinovirus infection.

Authors:  W S Barclay; W al-Nakib; P G Higgins; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

9.  Occurrence and frequency of coronavirus infections in humans as determined by enzyme-linked immunosorbent assay.

Authors:  M R Macnaughton
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Isolation of rhinoviruses and coronaviruses from 38 colds in adults.

Authors:  H E Larson; S E Reed; D A Tyrrell
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

View more
  245 in total

1.  Transmission dynamics and control of severe acute respiratory syndrome.

Authors:  Marc Lipsitch; Ted Cohen; Ben Cooper; James M Robins; Stefan Ma; Lyn James; Gowri Gopalakrishna; Suok Kai Chew; Chorh Chuan Tan; Matthew H Samore; David Fisman; Megan Murray
Journal:  Science       Date:  2003-05-23       Impact factor: 47.728

Review 2.  Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity.

Authors:  M K Slifka; R Ahmed
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

Review 3.  Certainty of success: three critical parameters in coronavirus vaccine development.

Authors:  David C Kaslow
Journal:  NPJ Vaccines       Date:  2020-05-25       Impact factor: 7.344

Review 4.  Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.

Authors:  Nicole Baumgarth; Janko Nikolich-Žugich; F Eun-Hyung Lee; Deepta Bhattacharya
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

5.  A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.

Authors:  Kenta Matsuda; Stephen A Migueles; Jinghe Huang; Lyuba Bolkhovitinov; Sarah Stuccio; Trevor Griesman; Alyssa A Pullano; Byong H Kang; Elise Ishida; Matthew Zimmerman; Neena Kashyap; Kelly M Martins; Daniel Stadlbauer; Jessica Pederson; Andy Patamawenu; Nathaniel Wright; Tulley Shofner; Sean Evans; C Jason Liang; Julián Candia; Angelique Biancotto; Giovanna Fantoni; April Poole; Jon Smith; Jeff Alexander; Marc Gurwith; Florian Krammer; Mark Connors
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

6.  Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.

Authors:  D E Wentworth; K V Holmes
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 7.  Is innate immunity our best weapon for flattening the curve?

Authors:  Leonard Angka; Marisa Market; Michele Ardolino; Rebecca C Auer
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

8.  Modeling shield immunity to reduce COVID-19 epidemic spread.

Authors:  Joshua S Weitz; Stephen J Beckett; Ashley R Coenen; David Demory; Marian Dominguez-Mirazo; Jonathan Dushoff; Chung-Yin Leung; Guanlin Li; Andreea Măgălie; Sang Woo Park; Rogelio Rodriguez-Gonzalez; Shashwat Shivam; Conan Y Zhao
Journal:  Nat Med       Date:  2020-05-07       Impact factor: 53.440

Review 9.  Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.

Authors:  Rudragouda Channappanavar; Stanley Perlman
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

10.  Human coronavirus NL63 and 229E seroconversion in children.

Authors:  Ronald Dijkman; Maarten F Jebbink; Nawal Bahia El Idrissi; Krzysztof Pyrc; Marcel A Müller; Taco W Kuijpers; Hans L Zaaijer; Lia van der Hoek
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.